Comment on EMA Draft Guideline on Computerised Systems and Electronic Data in Clinical Trials (EMA/226170/2021)

As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to EMA in 2021 about Comment on EMA Draft Guideline on Computerised Systems and Electronic Data in Clinical Trials (EMA/226170/2021) can be found below.

Comment on EMA Draft Guideline on Computerised Systems and Electronic Data in Clinical Trials (EMA/226170/2021)

Scroll to Top